{"id":"W4415364752","doi":"10.3389/jpps.2025.14721","title":"A survey of regulatory recommendations for waivers of in vivo bioequivalence studies of generic products for certain dosage forms by participating regulators and organisations of the International Pharmaceutical Regulators Programme. Part 2","year":2025,"lang":"en","type":"review","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Canada","funders":"World Health Organization","keywords":"Bioequivalence; Dosage form; Biopharmaceutics; Pharmaceutical industry; Pharmaceutical technology; Biopharmaceutics Classification System","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04280277,0.0007289808,0.001664226,0.008598914,0.0006482018,0.002058983,0.00215322,0.003535728,0.005089044],"category_scores_gemma":[0.05777838,0.0008044112,0.001809715,0.01183181,0.0008177377,0.002217619,0.001122874,0.00306305,0.001959638],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003055589,"about_ca_system_score_gemma":0.01231044,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006034686,"about_ca_topic_score_gemma":0.006842514,"domain_scores_codex":[0.9779282,0.006895869,0.006141501,0.001181381,0.007241863,0.0006113344],"domain_scores_gemma":[0.9133503,0.05230489,0.01608677,0.001846515,0.0155139,0.0008975579],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002927331,0.0001877656,0.002880751,0.04855198,0.0002627759,0.0002626589,0.0006893963,0.0008449223,0.003219721,0.01167585,0.1100646,0.8210669],"study_design_scores_gemma":[0.00008717126,0.0002692472,0.01567467,0.03717462,0.0004991033,0.0006656027,0.0004331226,0.0002737408,0.001991654,0.001519638,0.9413335,0.00007797991],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.007284414,0.93305,0.004612228,0.01826005,0.001054634,0.001234437,0.005855941,0.0001928584,0.02845544],"genre_scores_gemma":[0.03786087,0.9216212,0.01339229,0.013509,0.0004857618,0.001615811,0.006173976,0.0001238036,0.005217314],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.04280277,"threshold_uncertainty_score":0.2263654,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3901406023800169,"score_gpt":0.4692339028423009,"score_spread":0.07909330046228402,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}